Fig. 5From: Beneficial effects of curtailing immune susceptibility in an Alzheimer’s disease modelConfocal microscopy for detection of CD3 and FoxP3 positive cells in the hippocampus of 3xTg AD mice, following chronic treatment (12 months) with an anti-TNFSF10 monoclonal antibody (10 μg/animal twice a month, i.p.) or vehicle (10 μg/animal twice a month, i.p.). Panel a: each picture represents a single group of treatment and illustrates either the whole hippocampus (sagittal section) or, below, magnification of CA2-CA3 areas displaying specific CD3 (green) immunofluorescence (magnifications of respective white frames) in the mice following chronic treatment (12 months) with an anti-TNFSF10 monoclonal antibody (10 μg/animal twice a month, i.p.) or vehicle (10 μg/animal twice a month, i.p.). Panel b: immunofluorescence of hippocampi for CD3 (red) and FoxP3 (green) expression and co-localization from the same animal groups as above (merge column; DAPI = nuclear staining). The respective side columns are the lower magnification samples where the areas to analyze (CA1, CA2, CA3, and CA4) were magnified (framed in a green box). WT wild-type animals (n = 5/group).; AD: 3xTg-AD animals (n = 5/group)Back to article page